SCHEMBL12646381

SCHEMBL12646381

COc1ccc2c(c1)c1cccc3c4cc5c6ccc(OC)cc6c6cc(C(C)(C)C)cc(c4cc2c13)c65

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 7/20 0.41
▸ KDM4E B2RXH2 6/20 0.41
▸ ALDH1A1 P00352 6/20 0.41
▸ HPGD P15428 3/20 0.41
▸ MEN1 O00255 3/20 0.41
▸ KMT2A Q03164 3/20 0.41
▸ HSD17B10 Q99714 3/20 0.41
▸ L3MBTL1 Q9Y468 3/20 0.41
▸ HTT P42858 2/20 0.41
▸ NPC1 O15118 4/20 0.40
▸ RAB9A P51151 4/20 0.40
▸ LMNA P02545 2/20 0.40
▸ STAT1 P42224 2/20 0.40
▸ MAPK1 P28482 1/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.40
▸ TP53 P04637 1/20 0.38
▸ POLB P06746 2/20 0.38
▸ TSHR P16473 1/20 0.36
▸ GFER P55789 1/20 0.36
▸ MTNR1A P48039 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12589226 0.93 ACHE (0.40) MAPTKDM4EALDH1A1HPGDMEN1
SCHEMBL12646378 0.88 MAPT (0.46) MAPTKDM4EALDH1A1HPGDMEN1
SCHEMBL12589223 0.81 ACHE (0.48) MAPTKDM4EALDH1A1HPGDMEN1
SCHEMBL12927505 0.81 CYP1A2 (0.48) MAPTKDM4EALDH1A1HPGDMEN1
SCHEMBL16108132 0.79 MAPT (0.52) MAPTKDM4EALDH1A1HPGDMEN1
SCHEMBL13648834 0.78 MAPT (0.50) MAPTKDM4EALDH1A1HPGDMEN1
SCHEMBL13070418 0.77 MAPT (0.53) MAPTKDM4EALDH1A1HPGDMEN1
SCHEMBL12899486 0.76 ACHE (0.43) MAPTKDM4EALDH1A1HPGDMEN1
SCHEMBL17536913 0.75 MAPT (0.59) MAPTKDM4EALDH1A1HPGDMEN1
SCHEMBL2021618 0.75 MAPT (0.59) MAPTKDM4EALDH1A1HPGDMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110147731-A1 CONDENSED RING AROMATIC COMPOUND FOR ORGANIC LIGHT-EMITTING DEVICE AND ORGANIC LIGHT-EMITTING DEVICE HAVING THE SAME CANON KABUSHIKI KAISHA (JP) 2011-06-23 — — US disclosed
US-7919198-B2 Condensed ring aromatic compound for organic light-emitting device and organic light-emitting device having the same CANON KABUSHIKI KAISHA (JP) 2011-04-05 — — US disclosed
US-7919198-B2 Condensed ring aromatic compound for organic light-emitting device and organic light-emitting device having the same CANON KABUSHIKI KAISHA (JP) 2011-04-05 — — US disclosed
US-20100026171-A1 CONDENSED RING AROMATIC COMPOUND FOR ORGANIC LIGHT-EMITTING DEVICE AND ORGANIC LIGHT-EMITTING DEVICE HAVING THE SAME CANON KABUSHIKI KAISHA (JP) 2010-02-04 — — US disclosed
US-20100026171-A1 CONDENSED RING AROMATIC COMPOUND FOR ORGANIC LIGHT-EMITTING DEVICE AND ORGANIC LIGHT-EMITTING DEVICE HAVING THE SAME CANON KABUSHIKI KAISHA (JP) 2010-02-04 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100026171-A1 CONDENSED RING AROMATIC COMPOUND FOR ORGANIC LIGHT-EMITTING DEVICE AND ORGANIC LIGHT-EMITTING DEVICE HAVING THE SAME TYR, AHR, CRY1 MAPT 1521/4885KDM4E 1711/4885ALDH1A1 172/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback